Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion

Assiut University

Status and phase: Completed; Phase 4

Conditions: Family Planning

Treatments: Drug: diclofenac sodium (cataflam); Drug: hyoscine butyl bromide (buscopan)

Study type: Interventional

Funder types: Other

Identifiers

NCT02714231

DS-HB

Details and patient eligibility

About

The aim of our study is to compare the analgesic effect of oral diclofenac sodium versus oral hyoscine butyl bromide during intrauterine device insertion.

Enrollment: 100 patients

Sex: Female

Ages: 20 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women not taken analgesics or anxiolytics in the 24 hours prior insertion
• Women not taken misoprostol prior to intrauterine device insertion
• Women who will accept to participate in the study

Exclusion criteria

• Any contraindication to intrauterine device placement

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

100 participants in 2 patient groups

diclofenac

Experimental group

Description:

oral diclofuhenac sodium

Treatment:

Drug: diclofenac sodium (cataflam)

hyoscine

Active Comparator group

Description:

oral hyoscine butyl bromide

Treatment:

Drug: hyoscine butyl bromide (buscopan)